BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38500259)

  • 21. Mechanistic and clinical aspects of beta-lactam antibiotics and beta-lactamases.
    Kotra LP; Mobashery S
    Arch Immunol Ther Exp (Warsz); 1999; 47(4):211-6. PubMed ID: 10483868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-lactam antibiotic resistance: a current structural perspective.
    Wilke MS; Lovering AL; Strynadka NC
    Curr Opin Microbiol; 2005 Oct; 8(5):525-33. PubMed ID: 16129657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of beta-lactamases in the resistance of gram-negative bacilli to beta-lactam antibiotics.
    Acar JF; Minozzi C
    Rev Infect Dis; 1986; 8 Suppl 5():S482-6. PubMed ID: 3541133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-lactamases and beta-lactamase inhibitors.
    Williams JD
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 1():S3-7; discussion S26-7. PubMed ID: 10526867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibiotics.
    Sanders CC; Sanders WE
    J Infect Dis; 1986 Nov; 154(5):792-800. PubMed ID: 3490520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. β-Lactamases and β-Lactamase Inhibitors in the 21st Century.
    Tooke CL; Hinchliffe P; Bragginton EC; Colenso CK; Hirvonen VHA; Takebayashi Y; Spencer J
    J Mol Biol; 2019 Aug; 431(18):3472-3500. PubMed ID: 30959050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic and biochemical basis of resistance of Enterobacteriaceae to beta-lactam antibiotics.
    Wiedemann B
    J Antimicrob Chemother; 1986 Oct; 18 Suppl B():31-8. PubMed ID: 3491818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of β-lactam antibiotics to a bioinspired dizinc complex reminiscent of the active site of metallo-β-lactamases.
    Wöckel S; Galezowska J; Dechert S; Meyer F
    Inorg Chem; 2012 Feb; 51(4):2486-93. PubMed ID: 22296309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Beta-lactamase inhibitors].
    Nishiya H; Kunii O
    Nihon Rinsho; 1991 Sep; 49(9):2046-51. PubMed ID: 1960873
    [No Abstract]   [Full Text] [Related]  

  • 30. An overview of the response of bacteria to beta-lactam antibiotics.
    Greenwood D
    Rev Infect Dis; 1986; 8 Suppl 5():S487-95. PubMed ID: 3541134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. beta-Lactamases of increasing clinical importance.
    Bush K
    Curr Pharm Des; 1999 Nov; 5(11):839-45. PubMed ID: 10539991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial resistance mechanisms to beta-lactam antibiotics: assessment of management strategies.
    Dudley M
    Pharmacotherapy; 1995; 15(1 Pt 2):9S-14S. PubMed ID: 7753692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The emergence and implications of metallo-beta-lactamases in Gram-negative bacteria.
    Walsh TR
    Clin Microbiol Infect; 2005 Nov; 11 Suppl 6():2-9. PubMed ID: 16209700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffusion of beta-lactam antibiotics through oligomeric or monomeric porin channels of some gram-negative bacteria.
    Nitzan Y; Deutsch EB; Pechatnikov I
    Curr Microbiol; 2002 Dec; 45(6):446-55. PubMed ID: 12402087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro antibacterial activity and interactions with beta-lactamases and penicillin-binding proteins of the new monocarbam antibiotic U-78608.
    Zurenko GE; Truesdell SE; Yagi BH; Mourey RJ; Laborde AL
    Antimicrob Agents Chemother; 1990 May; 34(5):884-8. PubMed ID: 2193625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemiluminescence Detection of Hydrogen Sulfide Release by β-Lactamase-Catalyzed β-Lactam Biodegradation: Unprecedented Pathway for Monitoring β-Lactam Antibiotic Bacterial Resistance.
    Gholap SP; Yao C; Green O; Babjak M; Jakubec P; Malatinský T; Ihssen J; Wick L; Spitz U; Shabat D
    Bioconjug Chem; 2021 May; 32(5):991-1000. PubMed ID: 33896185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [beta-Lactam antibiotics--mechanisms of action and resistance in Enterobacteriaceae].
    Lausová A; Bujdáková H; Kettner M
    Epidemiol Mikrobiol Imunol; 1997 May; 46(2):73-80. PubMed ID: 9264797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-lactam antibiotics and beta-lactamases: two sides of a continuing story.
    Richmond MH
    Rev Infect Dis; 1979; 1(1):30-8. PubMed ID: 400938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zidovudine-β-Lactam Pronucleoside Strategy for Selective Delivery into Gram-Negative Bacteria Triggered by β-Lactamases.
    Rosales-Hurtado M; Sannio F; Lari L; Verdirosa F; Feller G; Carretero E; Vo-Hoang Y; Licznar-Fajardo P; Docquier JD; Gavara L
    ACS Infect Dis; 2023 Aug; 9(8):1546-1557. PubMed ID: 37439673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-activity relationships in the beta-lactam family: an impossible dream.
    Frère JM; Joris B; Varetto L; Crine M
    Biochem Pharmacol; 1988 Jan; 37(1):125-32. PubMed ID: 3276315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.